NDC 50458-575

Xarelto 155 mg granule, for suspension

On the label: Janssen Pharmaceuticals, Inc..

Germany: 2

Where it's made

FactoryWhereRoleLast FDA inspection
Bayer AGLeverkusen, GermanyMakes it, tests it and mills it Problems found, fixed voluntarilyMar 20, 2025 · 10 inspections, 2 with FDA action
Bayer AGWuppertal, GermanyMakes the active ingredient Problems found, fixed voluntarilyJan 18, 2023 · 8 inspections
AndersonBrecon Inc.Rockford, IL, United StatesPackages it No problems foundAug 19, 2026 · 11 inspections
Bayer AGBergkamen, GermanyTests it Problems found, fixed voluntarilyNov 14, 2024 · 7 inspections, 1 with FDA action
Bayer AktiengesellschaftBerlin, GermanyTests it and mills it Problems found, fixed voluntarilyJun 16, 2023 · 5 inspections
Janssen Pharmaceuticals Inc.Raritan, NJ, United StatesTests it No problems foundJun 17, 2022 · 8 inspections
Janssen Pharmaceuticals, Inc.Titusville, NJ, United StatesTests it Problems found, fixed voluntarilySep 25, 2026 · 11 inspections
Johnson & Johnson Private LimitedMumbai, IndiaTests it No problems foundApr 30, 2025 · 4 inspections
Patheon Inc.Mississauga, CanadaTests it and packages it Problems found, fixed voluntarilyFeb 24, 2023 · 7 inspections

Product details

Generic drug
Rivaroxaban: every company that makes it
Form
granule, for suspension, oral
Strength
155 mg
Approval
NDA NDA215859
On the market since
Dec 1, 2021
Package NDCs
50458-575-01
Official label
DailyMed (National Library of Medicine), updated Sep 10, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?